NASDAQ | ETF
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector.
It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.09% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.87% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 2.85% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.46% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 2.21% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.04% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.02% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.98% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.93% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.88% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.68% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.66% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.65% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |
| IMVT | Immunovant Inc | Healthcare | Biotechnology | 1.45% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.38% |
| INSP | Inspire Medical Systems Inc | Healthcare | Medical Devices | 1.30% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.26% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 1.17% |